WOCKHARDT LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Wockhardt Limited has informed the stock exchange regarding a press release dated June 28, 2024 titled "Successful use of investigational antibiotic Zaynich (Zidebactam/Cefepime -WCK 5222) to treat a cancer patient in US with chronic bilateral thigh infection caused by an extreme drug resistant Pseudomonas."